Cargando…

SP2-3 The impact of the COVID-19 global pandemic on oncology drug development, clinical research and R&D in Japan

Detalles Bibliográficos
Autor principal:	Shimizu, Toshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311552/ http://dx.doi.org/10.1016/j.annonc.2021.05.361

Ejemplares similares

Overcoming the impact of the COVID‐19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium
por: Shimizu, Toshio, et al.
Publicado: (2021)

The impact of R&D and innovation on global supply chain transition: GTAP analysis on Japan’s public R&D investment
por: Huang, Michael C., et al.
Publicado: (2020)

Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan
por: Shimomura, Akihiko, et al.
Publicado: (2017)

Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policy
por: Mizutani, Tomonori, et al.
Publicado: (2019)

Factors Affecting Drug‐Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan
por: Asano, Kunihito, et al.
Publicado: (2017)

Coming on Its Own, Global Oncology Research
por: Ginsburg, Ophira, et al.
Publicado: (2018)

Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420)
por: Lara Gongora, Aline B., et al.
Publicado: (2021)

How has the COVID-19 pandemic impacted clinical care and research in Neuro-Oncology?
por: Airth, Angus, et al.
Publicado: (2022)

SP2-4 Impact of COVID-19 on clinical practice and research in oncology in Singapore – experience of the National University Cancer Institute
por: Soo, Ross A.
Publicado: (2021)

Harmonization of Cardiovascular and Oncology and the Blossoming of Cardio-Oncology in Japan
por: Komuro, Issei, et al.
Publicado: (2020)

Barriers in access to oncology drugs — a global crisis
por: Barrios, Carlos, et al.
Publicado: (2022)

Innovation in Oncology Drug Development
por: Huber, Matthew, et al.
Publicado: (2019)

SP2-2 COVID-19 impact on the oncology practice in the USA
por: Ueno, Naoto T.
Publicado: (2021)

An Analysis of Global Research Trends and Top-Cited Research Articles in Cardio-Oncology
por: Suero-Abreu, Giselle Alexandra, et al.
Publicado: (2021)

The possible effects of the Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 on the practice of fertility preservation in female cancer patients in Japan
por: Kunitomi, Chisato, et al.
Publicado: (2022)

Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy
por: Ishiki, Hiroto, et al.
Publicado: (2023)

Analysis of the impact of non-compulsory measures on human mobility in Japan during the COVID-19 pandemic
por: Wu, Lingling, et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on other infections differs by their route of transmission: A retrospective, observational study in Japan
por: Komori, Akira, et al.
Publicado: (2022)

The Continuing Impact of Oncology Drug Shortages
por: Viale, Pamela Hallquist
Publicado: (2013)

R and D: essays on the economics of research and development
por: Hamberg, Daniel
Publicado: (1966)

Landscape of Global Oncology Research and Training at National Cancer Institute–Designated Cancer Centers: Results of the 2018 to 2019 Global Oncology Survey
por: Abudu, Rachel M., et al.
Publicado: (2019)

The COVID-19 Pandemic and Global Neurosurgery: The Situation in Japan and the Philippines
por: Matsumura, Hideaki, et al.
Publicado: (2021)

Competency-Based Workforce Development and Education in Global Oncology
por: Hammad, Nazik, et al.
Publicado: (2023)

Drug-Diagnostics Co-Development in Oncology
por: Jørgensen, Jan Trøst
Publicado: (2014)

Drug-Diagnostics Co-Development in Oncology
por: Simon, Richard
Publicado: (2013)

PHC: the future of oncology drug development
por: Yao, Yihong
Publicado: (2012)

Analysis of Global Drug Development Pathways and Postmarketing Safety in Japan: Local Studies May Reduce Drug‐Related Deaths
por: Okubo, Tomoko Kawamura, et al.
Publicado: (2019)

The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan
por: Komori, Akira, et al.
Publicado: (2021)

The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials
por: Ali, Jennyfa K., et al.
Publicado: (2021)

Global Survey of Clinical Oncology Workforce
por: Mathew, Aju
Publicado: (2018)

COVID-19: Global radiation oncology’s targeted response for pandemic preparedness
por: Simcock, Richard, et al.
Publicado: (2020)

Management of Gynaecological oncology diseases during COVID-19 global pandemic
por: de Andrade Vieira, Marcelo, et al.
Publicado: (2020)

Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
por: Nogami, Yuya, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on global health research training and education
por: Hou, Lifang, et al.
Publicado: (2020)

Current status of integrating oncology and palliative care in Japan: a nationwide survey
por: Uneno, Y., et al.
Publicado: (2020)

Assessment of Surrogate End Point Trends in Clinical Trials to Approve Oncology Drugs From 2001 to 2020 in Japan
por: Maeda, Hideki, et al.
Publicado: (2023)

Impact of COVID-19 on Gynaecological oncology; a global perspective
por: O'Neill, Danielle, et al.
Publicado: (2021)

Quantitative Translation in Immuno‐Oncology Research and Development
por: Bottino, Dean, et al.
Publicado: (2020)

A New Deal for Global Health R&D? The Recommendations of the Consultative Expert Working Group on Research and Development (CEWG)
por: Røttingen, John-Arne, et al.
Publicado: (2012)

Cardio-Oncology in Japan: The Rapidly Rising Sun
por: Oka, Toru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ilpsirqrlpo7rjcup8sfu0ipt4